These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 17681668

  • 1. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
    Tanaka J, Sugita J, Kato N, Toubai T, Ibata M, Shono Y, Ota S, Kondo T, Kobayashi T, Kobayashi M, Asaka M, Imamura M.
    Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells.
    Sugita J, Tanaka J, Yasumoto A, Shiratori S, Wakasa K, Kikuchi M, Shigematsu A, Kondo T, Asaka M, Imamura M.
    Ann Hematol; 2010 Feb; 89(2):115-20. PubMed ID: 19578849
    [Abstract] [Full Text] [Related]

  • 3. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM.
    Cancer Res; 2005 Apr 01; 65(7):2921-9. PubMed ID: 15805295
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
    Tanaka J, Toubai T, Miura Y, Tsutsumi Y, Kato N, Umehara S, Toyoshima N, Ohta S, Asaka M, Imamura M.
    Transplant Proc; 2004 Oct 01; 36(8):2511-2. PubMed ID: 15561299
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
    Zeddou M, Greimers R, de Valensart N, Nayjib B, Tasken K, Boniver J, Moutschen M, Rahmouni S.
    Biochem Pharmacol; 2005 Sep 01; 70(5):714-24. PubMed ID: 15978547
    [Abstract] [Full Text] [Related]

  • 6. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity.
    Wang Y, Xu H, Zheng X, Wei H, Sun R, Tian Z.
    Cell Mol Immunol; 2007 Oct 01; 4(5):377-82. PubMed ID: 17976318
    [Abstract] [Full Text] [Related]

  • 7. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G, Musto P, Cascavilla N, Di Giorgio G, Fusilli S, Zendoli F, Carotenuto M.
    Haematologica; 1998 Mar 01; 83(3):197-203. PubMed ID: 9573672
    [Abstract] [Full Text] [Related]

  • 8. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis.
    Correale J, Villa A.
    J Neuroimmunol; 2008 Mar 01; 195(1-2):121-34. PubMed ID: 18234356
    [Abstract] [Full Text] [Related]

  • 9. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J, van de Ven C, Cairo E, Hochberg J, Baxi L, Satwani P, Cairo MS.
    Exp Hematol; 2009 Oct 01; 37(10):1216-29. PubMed ID: 19638292
    [Abstract] [Full Text] [Related]

  • 10. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
    Xia G, He J, Zhang Z, Leventhal JR.
    Transplantation; 2006 Dec 27; 82(12):1749-55. PubMed ID: 17198271
    [Abstract] [Full Text] [Related]

  • 11. CD8 T cells expressing killer Ig-like receptors and NKG2A are present in cord blood and express a more naïve phenotype than their counterparts in adult blood.
    Warren HS, Rana PM, Rieger DT, Hewitt KA, Dahlstrom JE, Kent AL.
    J Leukoc Biol; 2006 Jun 27; 79(6):1252-9. PubMed ID: 16574769
    [Abstract] [Full Text] [Related]

  • 12. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M, Busch LK, Salazar-Fontana LI, Bellosillo B, Morte C, García P, López-Botet M.
    Eur J Immunol; 2005 Jul 27; 35(7):2071-80. PubMed ID: 15940674
    [Abstract] [Full Text] [Related]

  • 13. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
    Mutis T, Aarts-Riemens T, Verdonck LF.
    Haematologica; 2005 Oct 27; 90(10):1389-95. PubMed ID: 16219576
    [Abstract] [Full Text] [Related]

  • 14. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
    Gunturi A, Berg RE, Crossley E, Murray S, Forman J.
    Eur J Immunol; 2005 Mar 27; 35(3):766-75. PubMed ID: 15714583
    [Abstract] [Full Text] [Related]

  • 15. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
    Arlettaz L, Villard J, de Rham C, Degermann S, Chapuis B, Huard B, Roosnek E.
    Eur J Immunol; 2004 Dec 27; 34(12):3456-64. PubMed ID: 15517612
    [Abstract] [Full Text] [Related]

  • 16. Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cells.
    Chang CC, Satwani P, Oberfield N, Vlad G, Simpson LL, Cairo MS.
    Exp Hematol; 2005 Dec 27; 33(12):1508-20. PubMed ID: 16338494
    [Abstract] [Full Text] [Related]

  • 17. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.
    Bellón T, Heredia AB, Llano M, Minguela A, Rodriguez A, López-Botet M, Aparicio P.
    J Immunol; 1999 Apr 01; 162(7):3996-4002. PubMed ID: 10201920
    [Abstract] [Full Text] [Related]

  • 18. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M, Yamashita T, Fujii T, Nagamatsu T, Kozuma S, Taketani Y.
    J Reprod Immunol; 2006 Jun 01; 70(1-2):33-42. PubMed ID: 16488482
    [Abstract] [Full Text] [Related]

  • 19. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
    Asanuma S, Tanaka J, Sugita J, Kosugi M, Shiratori S, Wakasa K, Shono Y, Shigematsu A, Kondo T, Kobayashi T, Asaka M, Imamura M.
    Ann Hematol; 2011 Jun 01; 90(6):617-24. PubMed ID: 21107839
    [Abstract] [Full Text] [Related]

  • 20. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D, Cao Y, Luetkens T, Panse J, Faltz C, Arfsten J, Bartels K, Wolschke C, Eiermann T, Zander AR, Fehse B, Bokemeyer C, Kroger N.
    Haematologica; 2008 Mar 01; 93(3):423-30. PubMed ID: 18287134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.